First Time Loading...
I

Immune Pharmaceuticals Inc
OTC:IMNPQ

Watchlist Manager
Immune Pharmaceuticals Inc
OTC:IMNPQ
Watchlist
Price: 0.001 USD
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

IMNPQ Price Targets Summary
Immune Pharmaceuticals Inc

There are no price targets for IMNPQ.
IMNPQ Lowest Forecast
Wall Street Target
Not Available
IMNPQ Average Forecast
Wall Street Target
Not Available
IMNPQ Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Immune Pharmaceuticals Inc Competitors:
Price Targets
ARWR
Arrowhead Pharmaceuticals Inc
126% Upside
STOK
Stoke Therapeutics Inc
107% Upside
GNS
Genus PLC
47% Upside
T
1875
TOT BIOPHARM International Co Ltd
110% Upside
ARWR
Arrowhead Pharmaceuticals Inc
126% Upside
STOK
Stoke Therapeutics Inc
107% Upside
GNS
Genus PLC
47% Upside
T
1875
TOT BIOPHARM International Co Ltd
110% Upside
LEGN
Legend Biotech Corp
91% Upside
COX
Nicox SA
401% Upside
G
144510
GC Cell Corp
97% Upside
CPRX
Catalyst Pharmaceuticals Inc
79% Upside

Revenue
Forecast

Revenue Estimate
Immune Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Immune Pharmaceuticals Inc

Operating Income forecast
is not available for
Immune Pharmaceuticals Inc

Net Income
Forecast

Net Income Estimate
Immune Pharmaceuticals Inc

Net Income forecast
is not available for
Immune Pharmaceuticals Inc

See Also

Summary
IMNPQ intrinsic value, competitors valuation, and company profile.
DCF Valuation
IMNPQ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IMNPQ stock valuation using valuation multiples.
Wall Street Estimates
IMNPQ price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IMNPQ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMNPQ's stock price target?
Not Available

IMNPQ doesn't have any price targets made by Wall Street professionals.

ALPHA SPREAD
Join more than 133,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.